The European Cancer Screening Policy Index 2026
Every year, 2 million lives are lost due to cancer, many of them because the disease was detected too late. Early detection can raise survival rates by up to 13 times for some common cancers, while late detection can lead to less than 10% survival after five years.
Evidence-based cancer screening implementation remains one of the most effective ways to improve cancer outcomes, yet major disparities in policies and participation persist across Europe.
The 2026 European Cancer Screening Policy Index provides a comprehensive overview of cancer screening policies and performance across Europe, highlighting where progress is being made and where urgent action is still needed.
Key findings include:
- Persistent inequalities in screening policy and performance across Europe
- Screening participation stagnating or declining in several countries
- Core link between organised, population-based screening programmes and social equity in access
- Strong role of the European Union in supporting programme improvement and piloting for new approaches
This publication serves as a reference for policymakers, public health authorities and stakeholders working to strengthen cancer screening systems across Europe. To learn more about the methodology behind the Index and the policy recommendations stemming from these findings, visit the main Index page.
